Astrana Health (NASDAQ:ASTH) Shares Down 5.7% – Here’s Why

Shares of Astrana Health, Inc. (NASDAQ:ASTH) traded down 5.7% during trading on Tuesday . The company traded as low as $35.29 and last traded at $35.3360. Approximately 186,301 shares changed hands during trading, a decline of 66% from the average daily volume of 553,827 shares. The stock had previously closed at $37.47.

Analyst Ratings Changes

ASTH has been the subject of several recent analyst reports. Weiss Ratings upgraded shares of Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 1st. Barclays boosted their price target on shares of Astrana Health from $50.00 to $53.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Robert W. Baird set a $45.00 price target on shares of Astrana Health in a research report on Friday, May 8th. BTIG Research raised their price objective on shares of Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Finally, TD Cowen lifted their price objective on shares of Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Seven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $49.43.

Astrana Health Stock Up 3.8%

The firm has a 50-day moving average of $41.29 and a two-hundred day moving average of $32.70. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of 43.65 and a beta of 0.87. The company has a quick ratio of 1.35, a current ratio of 1.23 and a debt-to-equity ratio of 1.05.

Hedge Funds Weigh In On Astrana Health

A number of large investors have recently made changes to their positions in the business. Signaturefd LLC boosted its holdings in shares of Astrana Health by 57.9% during the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after purchasing an additional 388 shares during the period. Strs Ohio purchased a new stake in Astrana Health in the 4th quarter worth approximately $40,000. Tower Research Capital LLC TRC lifted its position in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after buying an additional 3,517 shares in the last quarter. State of Wyoming purchased a new stake in Astrana Health in the 2nd quarter worth approximately $132,000. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of Astrana Health during the 4th quarter valued at $228,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.